Abstract
The aim of the present study is to use [125I]iododomperidone (125I-DOM) as a novel radioligand for dopamine D2-receptor (D2R) imaging. Therefore, a 12 h in vitro stable [125I]iododomperidone was synthesized with a maximum radiochemical yield (RCY) of 95.5% in subsistence of chloramine-T (CAT) as an oxidant. Furthermore, molecular operating environment (MOE) design was employed to assess the determination of the [125I]iododomperidone structure. The product structure was confirmed by employing cold iodination reaction using iodine-127. Moreover, the computational data which obtained from PreADMET software proved the increase of lipophilicity of [125I]iododomperidone over that of unlabeled one. In a trial to confirm the targeting ability of [125I]iododomperidone to D2R, docking study was performed and showed a successful binding of the labeled compound to the receptor. The biodistribution profile of [125I]iododomperidone in normal mice showed a rapid and high uptake of the brain (5.6 ± 0.2% ID/g organ) at 5 min post injection (p.i.). Consequently, [125I]iododomperidone will be a potential unprecedented D2R imaging agent for diagnosis of various neuropsychiatric disorders.
Graphic abstract
Similar content being viewed by others
References
Mishra A, Singh S, Shukla S (2018) Physiological and functional basis of dopamine receptors and their role in neurogenesis: possible implication for Parkinson’s disease. J Exp Neurosci. 12:1179069518779829
van Noord C et al (2010) Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands. Drug Saf 33(11):1003–1014
Reddymasu SC, Soykan I, McCallum RW (2007) Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol 102(9):2036–2045
Davis KL et al (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148(11):1474–1486
Heritch AJ (1992) The dopamine hypothesis and neurophysiology concepts in schizophrenia. Rev Neurosci 3(3):207–216
Schlosser R, Schlegel S (1995) D2-receptor imaging with [123I]IBZM and single photon emission tomography in psychiatry: a survey of current status. J Neural Transm Gen Sect 99(1–3):173–185
Erlanson DA, McDowell RS, O’Brien T (2004) Fragment-based drug discovery. J Med Chem 47(14):3463–3482
Farrag NS et al (2017) Comparative study on radiolabeling and biodistribution of core-shell silver/polymeric nanoparticles-based theranostics for tumor targeting. Int J Pharm 529(1–2):123–133
Farrag NS, Abdel-Halim HA, Abdel Moamen OA (2019) Facile radiolabeling optimization process via design of experiments and an intelligent optimization algorithm: application for omeprazole radioiodination. J Labelled Comp Radiopharm. 62(6):280–287
Motaleb MA et al (2011) Radioiodinated paroxetine, a novel potential radiopharmaceutical for lung perfusion scan. J Radioanal Nucl Chem 292:629–635
Motaleb MA et al (2016) Synthesis, radioiodination and biological evaluation of a novel phthalimide derivative. J Radioanal Nucl Chem 307:363–372
Sivakumar T, Manavalan R, Valliappan K (2007) Development and validation of a reversed-phase HPLC method for simultaneous determination of domperidone and pantoprazole in pharmaceutical dosage forms. Acta Chromatographica. 18:130–142
Vilar S, Cozza G, Moro S (2008) Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem 8(18):1555–1572
Erfani M et al (2019) New 99 mTc-(CO)3-radiolabeld arylpiperazine pharmacophore as potent 5-HT1A serotonin receptor radiotracer: docking studies, chemical synthesis, radiolabeling and biological evaluation. J Labelled Comp Radiopharm. 62(4):166–177
Kalani MY et al (2004) The predicted 3D structure of the human D2 dopamine receptor and the binding site and binding affinities for agonists and antagonists. Proc Natl Acad Sci U S A. 101(11):3815–3820
Qin HL et al (2015) Molecular docking studies and biological evaluation of chalcone based pyrazolines as tyrosinase inhibitors and potential anticancer agents. RSC Adv. 57(5):46330–46338
Mohamed MS et al (2016) Design, synthesis, assessment, and molecular docking of novel pyrrolopyrimidine (7-deazapurine) derivatives as non-nucleoside hepatitis C virus NS5B polymerase inhibitors. Bioorg Med Chem 24(9):2146–2157
Sanad MH, El-Tawoosy M (2013) Labeling of ursodeoxycholic acid with technetium-99 m for hepatobiliary imaging. J Radioanal Nucl Chem 298:1105–1109
Safaa BC, Massoud A (2017) Radiolabeling of graphene oxide by Tchnetium-99m for infection imaging in rats. J Radioanal Nucl Chem 314:2189–2199
Attallah KM (2002) Pharmaceutical formulation, radiochemical and biological evaluation of some iodine-125 labeled cytotoxic compounds as possible radiotherapeutic agents. Department of Pharmaceutical Chemistry, Zagazig University
Motaleb MA, Moustapha ME, Ibrahim IT (2011) Synthesis and biological evaluation of 125I-nebivolol as a potential cardioselective agent for imaging b1-adrenoceptors. J Radioanal Nucl Chem 289:239–245
El-Azony KM et al (2008) An investigation of the 125I-radioiodination of colchicine for medical purposes. J. Labelled Compds. Radiopharm. 52(1):1–5
Knust EJ, Dutschka K, Machulla HJ (1990) Radiopharmaceutical preparation of 3-123I-α-methyltyrosine for nuclearmedical applications. J Radioanal Nucl Chem 144(2):107–113
Amin AM, Farrag NS, AbdEl-Bary A (2014) Iodine-125-chlorambucil as possible radioanticancer for diagnosis and therapy of cancer: preparation and tissue distribution. Brit J Pharm Res 4(15):1873–1885
El-Sharawy DM, El Refaye MS, Khater SI (2018) Radioiodination of cefoperazone with 125I and its biological distribution in mice arab. J Nucl Sci Appl 51(3):62–68
Verbruggen RF (1986) Kit preparation and rapid quality control of *I-labelled hippuran. Appl Radiat Isot 37:1249–1250
Pajouhesh H, Lenz GR (2005) Medicinal chemical properties of successful central nervous system drugs. NeuroRx 2(4):541–553
Mannhold R, van de Waterbeemd H (2001) Substructure and whole molecule approaches for calculating log P. J Comput Aided Mol Des 15(4):337–354
Sanad MH, Farag AB, Salama DH (2017) Radioiodination, molecular modelling and biological evaluation of aniracetam as a tracer for brain imaging. Egypt J Rad Sci Appl 30(2):131–143
Champion MC, Hartnett M, Yen M (1986) Domperidone, a new dopamine antagonist. CMAJ 135(5):457–461
Youssef AS, Parkman HP, Nagar S (2015) Drug-drug interactions in pharmacologic management of gastroparesis. Neurogastroenterol Motil 27(11):1528–1541
Motaleb MA et al (2011) Novel radioiodinated sibutramine and fluoxetine as models for brain imaging. J Radioanal Nucl Chem. 289:915–921
Acknowledgements
The authors would like to acknowledge Dr. Asmaa M. AboulMagd, Lecturer of Pharmaceutical Chemistry, Pharmaceutical Chemistry Department, Faculty of Pharmacy, Nahda University in Beni Sueif (NUB), for her contribution in the use of MOE and PreADMET softwares. The authors would like to thank Dr. A. M. Rashad, Central Laboratory for Elemental and Isotopic Analysis, Nuclear Research Center, Atomic Energy Authority, Cairo, Egypt, for his contribution in docking study.
Funding
Moreover, this research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Khater, S.I., El-Sharawy, D.M., El Refaye, M.S. et al. Optimization and tissue distribution of [125I]iododomperidone as a radiotracer for D2-receptor imaging. J Radioanal Nucl Chem 325, 343–355 (2020). https://doi.org/10.1007/s10967-020-07236-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-020-07236-z